Evidence summaries
Concise, sourced summaries of peer-reviewed studies and observational reports with clear links to the original publications.
Ibogaine Treatment Program is an independent resource on ibogaine for people researching ibogaine. We gather evidence, explain safety and legal issues, and organize practical questions so readers can make informed choices.
This page describes who we are, how we work, and the editorial standards that guide our content.
We publish for people researching ibogaine; our role is informational, not clinical. Our work combines summaries of peer-reviewed literature and public registries with plain-language explanations about how evidence and safety considerations are assessed.
Where helpful, our articles link to primary sources and regulatory guidance so readers can trace claims back to original documents; for example, widely referenced clinical summaries are often indexed on authoritative pages such as the National Library of Medicine on PubMed (Wikipedia's ibogaine overview) and official registry entries on government health sites like the U.S. National Institutes of Health (nih.gov).
"Independence and clarity: our editorial work is designed to reduce confusion for people evaluating complex, high-stakes options."
We focus on the organizational aspects of information: what questions people ask, how evidence is collected, and where to find primary documents. Content areas include summaries of safety literature, legal and access considerations, and practical procedural descriptions written for a general audience.
If you are orienting yourself on options and want an overview of services mentioned on this site, our Services page offers structured descriptions and links to informational resources; we reference that in contextual editorial pieces so readers can compare pathways in one place (review our services descriptions).
Concise, sourced summaries of peer-reviewed studies and observational reports with clear links to the original publications.
Plain-language explanations of commonly reported harms, monitoring needs, and risk mitigation strategies drawn from official guidance.
Guides to how regulation and access differ by jurisdiction and what that means for people researching options.
We combine systematic searches of the scientific literature with consultation of registries and official documents. Where appropriate we cite clinical trial registries, government health advisories, and academic reviews to triangulate claims. For transparency, articles include links to the primary sources we used so readers can verify context.
Editorial checks include source attribution, evaluation of study design, and noting conflicts or gaps in the evidence base. For general standards on assessing medical evidence we reference established frameworks such as those presented by universities and public health bodies (Cochrane).
Our audience is people researching ibogaine who need balanced, sourced information to inform personal decisions or further research. We do not provide clinical recommendations, diagnosis, or legal advice. If you need medical or legal guidance, consult licensed professionals in your jurisdiction.
To explore organizations listing services and logistical options, readers sometimes consult external directories; when such directories are mentioned, we link to them contextually and do not endorse specific providers — for example, third-party directories consolidate regional listings (best ibogaine treatment centers directory).
Ibogaine Treatment Program is an independent information resource. It is not a clinic, medical provider, or licensed treatment center, and its content is not medical or legal advice.
Independence · Plain language · Audience-specific evidence · No fabricated credentials
Explore the site or return to our main hub for topical content and organized guides.
Visit the main hub